TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Clarient, Inc. Directors Face Investor Investigation Over Possible Breaches Of Fiduciary Duties

  • If you are a current investor in Clarient, Inc. (NASDAQ:CLRT) common or preferred shares, and/or have any information relating/helpful to the investigation, you have certain options and should you contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After Clarient, Inc announced that it entered into an agreement for GE Healthcare to acquire Clarient an investigation concerning whether the buyout is unfair to investors in Clarient, Inc. (NASDAQ:CLRT) shares was announced. The investigation by a law firm concerns whether GE Healthcare, Clarient, Inc. and its Board breached their fiduciary duties owed to Clarient, Inc. (NASDAQ:CLRT...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: